Commercialization Committee


The Commercialization Committee strives to:

  • Be the global communication hub between therapeutic societies, regulatory policy makers, institutional stem cell centres and industry for the advancement of clinical investigation in cell therapy and regenerative medicine.

Projects and Objectives

  • Drive industry/academic partnerships.
  • Identify and develop reimbursement roadmaps and partner to influence coding and pricing decisions.
  • Assist in developing partnerships and liaisons with appropriate clinical societies and/or sister societies.
  • The inaugural Commercialization Signature Series hosted on September 29, 2016.



Committee Members


Miguel Forte, MD, PhD
mC4Tx, Bone Therapeutics
Brussels, Belgium

Julie Allickson, PhD, MSc, MT(ASCP)
Wake Forest Institute of Regenerative Medicine
Winston-Salem, NC, United States
Tim Allsopp, PhD
Pfizer Regenerative Medicine
Cambridge, United Kingdom
Dolores Baksh
GE Healthcare
Walkersville, MA, United States
Gerhard Bauer, PhD
UC Davis
Sacramento, CA, United States
Lynn Csontos
STEMCELL Technologies
Vancouver, BC, Canada
Dawn Driscoll, PhD, MBA
DCi Biotech
Perth, Australia
Simon Ellison, MBA
Fisher BioServices
London, United Kingdom
Ronald Fedechko
Cambridge, United Kingdom
John Fink, MSc
Brooks Life Science Systems
Chelmsford, MA, United States
Ian Gaudet, PhD
PCT Caladrius
Mountainview, CA, United States
Dina Isyemina, MSc
Terumo BCT
Lakewood, CO, United States
Nancy Johansen
Miltenyi Biotec
Woburn, MA, United States
Ohad Karnieli, PhD, MBA
Karnieli Inc.
Haifa, Israel
Eric Law
Celgene Cellular Therapeutics
Warren, MI, United States
Bruce Levine, PhD
University of Pennsylvania
Philadelphia, PA, United States
Aby Mathew, PhD
BioLiofe Solutions
Bothell, WA, United States
Robert Mays, PhD
Cleveland, OH, United States
Michael Mendicino, PhD
Hybrid Concepts International, LLC
Grand Island, NY, United States
Bill Milligan, BSc
Steminent Biotherapeutics
Vancouver, BC, Canada
Julie Murrell, PhD
EMD Millipore
Bedford, MA, United States
Brian Newsom, MSc
Thermo Fisher Scientific
Knoxville, TN, United States
Jessie Ni
Irvine Scientific
California, United States
Nathan Smith
Cell Therapies Pty Ltd
East Melbourne, VIC, Australia
David Williams, PhD
Loughborough University
Loughborough, United Kingdom
Claudia Zylberberg, PhD
Akron Biotech
Boca Raton, FL, United States

Ohad Karnieli, PhD, MBA
Pluristem Therapeutics
Haifa, Israel
Nathan Smith
Cell Therapies Pty Ltd
East Melbourne, VIC, AUS
Nathan Smith
Cell Therapies Pty Ltd
East Melbourne, VIC, AUS

© 2017 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.